Techniques: Patient-derived rectal organoids to predict response to cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics in cystic f

Assays and screens

TECHNOLOGY: Cellular assays; 3-D models

A patient-derived, rectal organoid-based assay could be used to predict response to CFTR-targeted therapeutics

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE